Skip to main content
. 2020 May 16;159(3):1170–1172.e1. doi: 10.1053/j.gastro.2020.05.034

Figure 1.

Figure 1

(A) Prognosis of patients with COVID-19 with hypertension in the ACEI/ARB and non-ACEI/ARB groups. (B, C) Kaplan-Meier curves for the cumulative probability of (B) gastrointestinal involvement and (C) abnormal liver function during 30-day follow-up in the ACEI/ARB or non-ACEI/ARB groups among 100 patients with COVID-19 with hypertension.